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“The secret of life is to fall seven times and to get up eight times” 
Paulo Coello 
  
   
ABSTRACT 
It is important to understand gut B cell differentiation, from the activation of cells at 
inductive lymphoid sites to the formation of gut plasma and memory B cell, to be able 
to develop efficient oral vaccines but the process is incompletely defined.  To address 
this we developed an adoptive transfer system based on B1-8hi/GFP+ NP-specific B 
cells and NP-CT, a hapten-carrier complex that allows us to follow antigen-specific 
IgA responses following oral immunization. In paper (Ι) we provide evidence for 
early migration of activated B cells via draining lymph and blood to germinal centers 
(GC) in Peyer’s patches (PP) spatially distinct from where the cells originated, thus 
explaining how synchronization between PP may be achieved. We address the 
requirements for activated PP B cells to re-enter GC, and demonstrate the necessity of 
antigen and expression of CD40 on B cells. Gut IgA plasma cells did not form from B 
cells lacking CD40 in a competitive bone marrow transfer experiment, suggesting that 
the GC pathway dominate their formation. In paper (II) we show that activated PP B 
cells interact with M cells and antigen in the sub epithelial dome (SED) of PP. B cells 
in SED had an IgD-, GL7- and CCR6+ phenotype and migrated rapidly towards the GC 
after interacting with antigen. We hypothesize that during a PP immune response, B 
cells intermittently sample and transport antigen from the basal pockets of SED M 
cells and that this feeds antigen into the GC to maintain the response. Paper (III) 
demonstrates that gut memory B cells and long-lived plasma cells are not closely 
clonally related. We propose that the plasticity of PP allows these two classes of B 
cells to evolve in temporarily or anatomically separate GC processes, leading to 
diverse low-affinity memory B cells and clonally restricted high-affinity plasma cells. 
In this way, the plasma cells are focused on antigens currently in the gut whereas a 
broader repertoire of memory cells is able to recognize related antigens. On 
reactivation, the mucosal memory B cell response was dominated by clonally selected, 
high-affinity cells, leading to the formation of plasma cells of high affinity. Paper (IV) 
demonstrates that germ free (GF) mice largely lack IgA producing plasma cells 
despite having intact B cell expansion and differentiation in PP GC. This suggests that 
lack of bacterial colonization is associated with that the gut lamina propria (LP) 
cannot attract and/or host IgA producing plasma cells. An oral immunization with 
NP-CT did not only induce antigen-specific IgA plasma cells in the LP but also largely 
restored polyclonal IgA production in the gut. Thus, in GF mice, CT induced the LP 
effector site to attract polyclonal IgA producing plasma cells in a manner similar to 
that seen following bacterial colonization. Taken together, this thesis demonstrate 
several features that are unique to activated gut B cells, and show that these are 
relatively mobile and not as restricted to a single GC as during systemic responses. 
 
Keywords: Germinal centers, Sub-epithelial dome, NP-CT, B1-8hi/GFP+ NP-specific B 
cells, Peyers patches, Lamina propria, Germ free mice 
  
 
SAMMANFATTNING PÅ SVENSKA 
Det är viktigt att förstå hur B celler utvecklas i tarmen för att kunna utveckla 
orala vacciner. Det finns dock många obesvarade frågor om denna process. Vi 
har utvecklat en metod som baseras på att föra över B1-8hi/GFP+ B cells som 
känner igen NP till mottagarmöss och sedan immunisera dessa oralt med NP-CT, 
ett hapten/bärare komplex. I arbete (I) så visar vi att B celler kan lämna det 
organsystem där de aktiveras i germinalcentrum (GC) och sedan via lymfan och 
blodet ta sig in i GC i andra Peyerska plack (PP). Detta förklarar hur olika PP kan 
kommunicera med varandra under ett immunsvar. Vi visar att antigen och CD40 
på B cellen är nödvändiga för att detta skall kunna ske. Genom att byta ut 
benmärgen i möss visar vi att CD40 är nödvändigt för att IgA producerande 
plasmaceller i tarmen skall bildas, vilket tyder på att den absoluta majoriteten 
bildas i GC. I arbete (II) visar vi att aktiverade B celler i PP interagerar med M 
celler och antigen i ett område som kallas den subepitelial domen (SED). Då IgD-, 
GL7- och CCR6+ B celler vid M celler känt igen antigen så rör de sig snabbt mot 
GC. Vi föreslår att under ett immunsvar så kommer B celler då och då besöka 
SED för att undersöka om det fortfarande förekommer antigen och transportera 
antigen till GC för att underhålla immunsvaret. Arbete (III) visar att minnesceller 
och lång-livade plasmaceller inte är nära besläktade vad gäller de gener för 
antikroppar som används. Baserat på detta föreslår vi att dessa celler kommer 
från GC som skiljer sig från varandra, antingen spatialt eller tidsmässigt, vilket 
leder till en större variation bland minnescellerna som också har antikroppar 
med lägre bindningsstyrka än plasmacellerna. Genom denna mekanism kommer 
plasmacellerna att fokuseras mot det antigen som för tillfället finns i tarmen, 
medan minnescellerna kommer att kunna känna igen en större bredd av olika 
närbesläktade antigen. I arbete (IV) studerar vi möss som växt upp sterilt i 
avsaknad av pathogener och finner att de i stor omfattning saknar IgA 
producerande plasmaceller trots att deras GC i PP verkar normala. Detta tyder på 
att slemhinnan i tarmen inte mognat färdigt och därför inte kan 
attrahera/upprätthålla IgA plasmaceller. En oral immunisering med NP-CT leder 
dock till att det inte bara bildas antigen-specifika plasmaceller utan också 
plasmaceller som inte känner igen detta antigen. Koleratoxin (CT) verkar därför 
kunna orsaka samma förändringar av slemhinnan som sker då bakterier växer i 
tarmen. Huvudfynden i denna avhandling kan sammanfattas som att vi 
definierar ett flertal mekanismer som är unika för aktiverade B cells i tarmen, och 
visar att dessa aktiverade celler är relativt rörliga och inte så bundna till ett enda 
GC som man normalt tror sker under ett svar mot ett antigen som tillförs 
kroppen via andra vägar.   
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1 INTRODUCTION 
Without an immune system we would not survive. Our body is constantly 
under attack by many different microbial pathogens of which bacteria, 
viruses as well as parasites can cause infections, in worst cases leading to 
death [1] [2]. The immune system is composed of a vast network of tissues 
and cells that help distinguish between self from non-self. The innate 
immune system consists of many types of cells such as neutrophils, 
monocytes, macrophages, mast cells dendritic cells and many more  [3]. The 
adaptive immune system, on the other hand, is composed of lymphocytes of 
only two types, B and T lymphocytes [4] [5]. The recognition of self and non-
self is under the control of the T lymphocytes [6] [7] . Immune responses 
most often depend on both the innate and the adaptive immune system [8] 
[9] [10] [11]. The initial response to foreign antigen is provided by the innate 
immune system and activated through pattern receptor recognition (PRR), 
which is genetically an inherent set of receptors. An example of this type of 
receptor is the toll like receptors (TLR) [12] [13] [14] [15]. Lymphocytes have 
more complex receptors that are unique to specific antigens and which are 
continuously generated as new B and T lymphocytes are formed. This 
requires the recombination of receptor encoding genes. The innate immune 
response does not develop memory cells, whereas this is a hallmark of the 
adaptive immune system. Memory T and B cells are critical for a healthy life 
and vaccines are made to stimulate the development of strong protective 
memory lymphocytes [16] [17] [18] [19]. Moreover, activation of B 
lymphocytes also results in the formation of long-lived plasma cells, which 
reside in the bone marrow or at mucosal sites, where they maintain the 
presence of antibodies [20] [21] [22]. This thesis focuses on B lymphocytes, 
from now on termed B cells, in the gastrointestinal tract. I have studied how 
B cells are activated through oral immunization and how the gut IgA 
response is regulated and which sites are critical for the development of 
immune protection against attacking intestinal pathogens. 
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1.1 General concepts in B cell development 
Being an integral part of the adaptive immune response, the B cells represent 
a separate function and lineage from the T cells [23] [24]. Starting with 
studies by  Paul Ehrlich in Berlin in the 1890’s it was identified that 
circulating antibodies, called antitoxins were important to protect against 
diphtheria and tetanus, but the existence of the antibody producing B cell 
came much later. Niels Jerne and others proposed that the antibodies were 
formed by B lymphocytes as late as in the 1950s [25]. Max Cooper and Robert 
Good in 1965, in an experimental setup using chicken were able to 
demonstrate that specific cells, B cells, develop in Bursa of Fabricus (bone 
marrow equivalent in birds) and were responsible for antibody production 
[26]. Apart from antibody production B lymphocytes have also been found to 
present antigen to T cells and for production of regulatory cytokines. Today 
B cells lineage differentiation and maturation has been widely studied and 
documented.  
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An outline of B cell differentiation is shown below, 
 
 
 
Figure 1. Overview of B cell Lineage differentiation: HSC (hematopoietic stem cells; 
MPPs (multipotent progenitor); CLPs (common lymphoid progenitors) 
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1.2 B cell Activation 
Activation of B cells occurs when an antigen is recognized and bound to the 
B cell receptor (BCR), which is a membrane bound immunoglobulin of the 
IgD and IgM class. Once activated, B cells undergo massive expansion and 
finally they can differentiate into plasma cells and memory B cells. There are 
mainly two types of immune responses, those that are dependent on CD4 T 
cells [27] and those that can undergo with B cells alone, which are called T 
cell-independent immune responses [28] [29]. Most immune responses are 
against protein antigens and these all require the involvement of CD4 T cells. 
However, some lipids, and carbohydrates can stimulate a strong B cells 
response in the absence of T cells. This kind of activation is termed thymus 
independent (TI), while responses to protein antigens are named thymus 
dependent (TD). 
 
1.2.1 T cell independent B cells responses 
This route of B cells activation is divided into two subclasses, type 1 and type 
II [30] [31] [32] . For example, lipopolysaccharides (LPS), are type I antigens 
and have the ability to induce cell division through cross-linking of the BCR. 
LPS and certain nucleic acids like CpG can also activate B cells through TLRs, 
which leads to proliferation and differentiation of B cells with many 
specificities and, thus, called polyclonal activation. Immune responses 
against these types of antigens are dominated by IgM antibodies and are 
most often of low affinity as these B cells do not undergo isotype switching 
and affinity maturation processes.  
 
Type II antigens are typically polysaccharides, involving strong BCR cross 
linking [33]. Epitope density is crucial for B cells activation by type II 
activation as it is achieved though cross-linking of multiple BCRs. A low 
density is insufficient to stimulate a response while a high density can result 
in unresponsiveness, also termed anergy [34] . 
 
TI responses are faster than TD responses and days after a TI challenge a 
significant amount of plasma cells can be seen in the extra follicular regions 
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of the lymph node or spleen [35, 36]. A majority of these plasma cells die 
within a couple of weeks [33]. 
 
1.2.2 T cell dependent B cells responses 
My thesis project is focused on studies of how to stimulate naive B cells 
(IgDhi) in the gut. We have a reporter mouse that expresses GFP+ in all B cells 
that are specific for the NP-hapten. After adoptive transfer of these B cells 
into naïve recipient mice we study both T cell-dependent and T-cell 
independent IgA responses in the gut and at other locations. The T cell-
dependent responses take longer time to develop than TI responses [37] [38]. 
They have two phases an early and late phase. In the early phase B cell 
expansion occurs in germinal centers (GC) that develop in the B cell follicle in 
the lymph node and this phase is followed by isotype switching and affinity 
maturation where also memory cells and long-lived plasma cells are formed 
[39] [40] [41].   
 
Dendritic cells (DC) present antigen to naive T cells in the T cell area which 
results in the activation of the specific T cells. Although T cells and B cells 
recognize the same antigen, T cells react to peptides presented on MHC class 
II molecules on the DCs, while the B cells recognize conformational epitopes 
and do not need assisting DCs to get activated. Both types of activated cells 
move from the B cell follicle to T cell-B cell border region, where cognate 
antigen-recognition occurs, and prior to the formation of the GC, witnin 3-7 
days [42].  Both activated B cells and the activated CD4 T cells participate in 
the GC reaction, which is established in the B cell follicle area around a 
network of follicular dendritic cells (FDC). 
1.3  Mucosal Immune system 
A major site for exposure to microorganisms and food antigens is the gut 
mucosa. This is because the intestinal mucosa constitutes of large surface 
area often exceeding 300 m2 in humans [43]. To protect against pathogens the 
gut mucosal immune system produces IgA antibodies and the production of 
IgA in the gut is indisputably the largest amount of antibody produced per 
day in the whole body [44] [45] [46] [47] [48].  
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The mucosa-associated lymphoid tissue (MALT) [49] and the gut-associated 
lymphoid tissues (GALT) [50] are highly organized lymphoid tissues, which 
in the gut includes Peyer’s patches (PP), cryptopathces (CP) and isolated 
lymphoid tissues (ILF) [51]. MALT and GALT are divided up into an 
inductive site and an effector site. In GALT the major inductive site is PP 
while the effector site is the lamina propria (LP) of intestine. This site hosts 
effector T cells, memory T cells and plasma cells that emanate from the 
inductive site [43]. Associated to GALT is the draining lymph node, i.e the 
mesenteric lymph nodes (MLN). Much remains to be understood about the 
function and development of these tissues [52]. My thesis work is an attempt 
to better define certain regulatory parameters that are essential for a 
functional gut IgA system. 
1.4 The Gut Immune system  
The intestinal mucosal surface has small finger link projections known as 
villi, which hosts the immune cells. The PPs are protruding dome like 
structures in the mucosa and represents the organized lymphoid tissue 
dominated by naive B and T lymphocytes. But, also macrophages, dendritic 
cells, and other stromal cells are abundant in this tissue. The follicle 
associated epithelium (FAE) that separates the lumen from the tissue hosts 
microfold (M) cell [53], which is specialized in taking up antigens from the 
lumen [54] [55].  
 
To understand the function and organization of the gut IgA system it is 
critical to know where immune responses are initiated [56] [57]. Micro 
anatomical studies on IgA B cell responses have identified the PP as the 
major site for immune induction, but at times also the ILF and MLN could be 
involved [58] [59] [60, 61]. 
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Table 1: Structures and tissues of Gut immune system 
Structures of gut 
Mucosa 
Location Function 
Peyer’s patches Seen in the Ileum 
region of the small 
intestine 
Major site for plasma 
and memory B cell 
development. Also the 
key site for the 
coordinating immune 
response to pathogens 
in the gut. 
Mesenteric Lymph 
nodes 
Seen close to the wall of 
the small intestine  
Specialized structure 
for the initiation of 
immune response.  
Lamina propria Beneath epithelium Absorbs digestive 
products through 
network of blood 
vessels to the rest of the 
body. 
Crypts Within lamina propria 
in small intestine 
around villi 
Location for replicating 
stem cells, Paneth cells 
and goblet cells 
Villi Outer part of gut wall 
facing lumen 
Region of epithelial 
cells 
   
Cells of gut Mucosa Location Function 
Stem cells in crypts Seen in the bottom of 
crypts between Paneth 
cells 
Active self-renewal of 
the epithelium 
Goblet cells Intestinal crypts Secretes mucous layer 
Paneth cells Intestinal crypts Produce anti-microbial 
peptides 
Intestinal effector T 
cells 
LP and Intraepithelial 
cells (IEC) 
Mediate immune 
homeostasis 
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Intestinal T regulatory 
cells 
PP, LP, MLN Suppresses immune 
response to commensal 
microbes. Maintain 
immune homeostasis 
Intestinal B cells PP, ILF, MLN Source of IgA in LP 
Intestinal dendritic cells PP, LP, MLN Regulates T cell homing 
to small intestine. 
Present microbial 
peptide to T cells for 
activation 
Intestinal Macrophages LP Regulates inflammatory 
responses to bacteria 
and other harmful 
pathogens. Scavenge 
dead cells and foreign 
debris 
Microfold (M cells) FAE in  PPs Responsible for the 
uptake of antigen and 
present then to MALT 
Intestinal epithelial cells 
(ECs) 
Lining of small intestine Secrete anti-microbial 
peptides, cytokines in 
response to microbes, 
recruit DCs. Present 
antigens to T cells and 
maintain immune 
homeostasis 
Innate lymphoid cell 
type 2 (ILC 2) 
LP Induces mucous 
production and 
contributes to immune 
response to helminth 
worms 
Innate lymphoid cell 
type 3 (ILC 3) 
LP Development of 
intestinal lymphoid 
organs, gut homeostasis  
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1.4.1 Peyer’s patches (PP) 
 
The PPs have been named after Johann Conrad Peyer, who defined them as 
lymph nodules in the small intestine as early as in 1673 [57, 62]. These 
structures are the major inductive sites for IgA responses and have been well 
described already 50 years ago, but their detailed immune function still 
remains to be investigated further [63] [64]. PPs can be divided into 4 main 
areas, i) the B cell follicle, where the GC develops, ii) the overlying follicle 
associated epithelium (FAE) and iii) the sub epithelial dome (SED) and 
located between the follicles & the T cell zone [57]. The PP is richly provided 
with lymphatic and blood vessels. The FAE and the M cells transport luminal 
antigens from the lumen to the SED. At this site the DC are known to take up 
antigen and migrate to the T cell zone, but also macrophages can take up 
antigen in the SED [65] [66] [67] Whether B cells at this location have an 
antigen transporting function is not known, but a few reports have indicated 
that could be the case. Much remains to be understood about the SED region 
and its functions in the IgA response. In the follicle, activated CD4 T cells and 
GC B cells interact and this occurs through the CD40L-CD40 molecules on 
the surface of the respective cell subsets [68] [69] [70]. However, the exact 
mechanism by which B cell responses are stimulated and regulated in the 
PPs is incompletely understood [57]. 
 
1.4.2 Mesenteric lymph nodes (MLN) 
 
The lymph from the small and large intestines drains to the MLN [71] [72]. In 
fact, today, we have precise knowledge about which nodes that drain the 
small and large intestines. Also, GC and B cell responses are observed in 
MLN, but to what extent these are important for the IgA plasma cell 
responses in the LP are not completely clear. But, MLN could be a 
complementing site for IgA B cell responses [73]. Rather, the MLN is the 
major site for T cell tolerance induction to food proteins, constituting a 
protective wall against microbial invasion from the intestine [71] [74]. This 
way the MLN helps preserve antigenic ignorance to commensal bacteria [71] 
[74]. The migratory CD103+ DCs in the LP take up antigen and carry antigen 
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to the MLN where naive CD4 T cells are primed. These T cells regulate 
immune reactions by dampening unwanted reactions and this way 
contributes to homeostasis in the gut [75] [71].  
 
 
1.4.3 Lamina propria (LP) 
 
The LP is a network of loose connective tissue in the mucosa. It is the effector 
site in the gut immune system, where plasma cells reside and plasma blast 
differentiate into plasma cells. Microscopic analysis of tissue sections of the 
gut show that the LP of the villi is filled with IgA producing plasma cells. 
The plasma cells produce dimeric IgA which is bound to a joining chain (J-
chain). The complex binds to the polymeric Ig receptors (pIgR) on the 
basolateral membrane of the epithelial cell and is then taken up and 
transported through the cell into the gut lumen [76]. Activated B cells from 
GALT acquire homing receptors that enable them to migrate back to the gut 
LP. These cells migrate via the lymphatics to the MLN into the thoracic duct 
and after circulating in the blood they enter the LP [77]. These B cells are 
imprinted with homing receptors specific for the gut, i.e. α4β7 integrin, 
CCR9 and CCR10 [78] [79]. At the effector site the endothelial cells in the 
blood vessels carry specific addressin cell adhesion molecules, such as 
moleculae-1 (MAdCAM-1). This is the key attractant for the integrin α4β7 to 
the LP [80] [81] [82] [83]. In addition, other homing receptors are also 
required for final homing to the gut tissue and  TECK (CCL25), expressed in 
the crypt epithelium of the small intestine interacts CCR9-expressing 
lymphocytes and CCL28 (MEC) attracts CCR10-expressing cells to large 
intestine [84] [85] [86]. 
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1.5 Micro-anatomy of PP 
 
1.5.1 Antigen uptake in PPs 
 
We lack a detailed understanding of the mechanism for antigen uptake by M 
cells. These cells express Dectin-1 which facilitates the uptake of glycosylated 
bacteria [57] [87], but is not required for the uptake of IgA coated bacteria 
[88]. Also other molecules are expressed by M cells such as gangliosides 
which enables cholera toxin to access the tissue [89] and certain lectins 
facilitate up-take by M cells [90] [91]. The M cell, contrary to epithelial cells 
expresses glycoprotein-2 (GP2), which recognizes FimH (type of pili) carried 
by certain bacterial commensals and pathogens. The basal side of the M cell 
hosts large pockets that can harbors different types of cells, including IgD+ 
and IgD- B cells, DCs, Macrophages and T cells [90] [92] [66] [93] [94] [62]. 
The function of these pockets is still poorly known and it has been speculated 
to be important for antigen transport to the B cell follicle and T cell zone.  
 
1.5.2 Sub epithelial dome (SED) 
 
The sub-epithelial dome (SED) is a specialized structure that is in close 
proximity with the M cells in the PP’s. There are several theories regarding 
the function of the SED [95] [96] [97] [98] and which cells traffic to and from 
this site [99] . My thesis work has taken a special interest in the B cells of the 
SED (Paper II in thesis). Apart from activated B cells the SED hosts a high 
density of classical DCs, CD11b+CD8-DCs and CD11b-CD8- DCs [100]. 
However, also naive B cells along with macrophages, T cells, RORγt+ ILCs 
have been identified in the SED [98]. It has been well documented that CCR6 
is required for cells to appear in the SED region and both T and B cells 
express this membrane molecule. 
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1.5.3 Germinal centers (GC)  
 
The GC reaction seen in B cell follicles during a T cell-dependent B cell 
response is complex [101]. GC was first defined by Walther Flemming in 1884 
[102], as he observed sites where lymphocytes undergo mitosis in the 
follicular regions of the lymph nodes [103]. Today we know much more 
about the GC reaction and we know that it is critical for the affinity 
maturation of the antibody response, which is achieved through somatic 
hyper mutation (SHM) [104], and class-switch recombination (CSR) is also 
achieved in the GC [105] [101] [103] [106] [107]. Micro anatomical studies of 
GC show it is divided into two zones, a dark zone (DZ) and a light zone (LZ). 
The DZ is the active site for cell division, and the LZ harbors the FDC 
network which promotes the SHM and CSR. High levels of activation-
induced cytidine deaminase (AID) are a hallmark of B cells in the DZ, also 
called as centroblasts. In the LZ the B cells are called centrocytes, as this site 
promotes contacts with CD4 T follicular helper cells (Tfh) [108] [109]. Within 
the germinal center, B cells move between dark and light zone in response to 
CCL12 (DZ) to CXCL13 (LZ) [109] [110]). Inside the GC multiple rounds of 
selection and mutation occurs [106], during this process many B cells 
undergo apoptosis and are removed by macrophages [105]. The result of the 
GC reaction is also memory B cells and long lived plasma cells, which are 
components that T-cell independent antigens do not stimulate. 
 
1.5.4 Special features of PP GC and gut LP 
 
This study is addressing which regulatory functions that govern gut IgA 
responses following oral immunization. The study dissects five important 
themes that we have discovered in the mouse model. The first is whether we 
develop memory B cells following oral immunizations. The second is the site 
and kinetics for B cell responses in GALT following oral immunization. The 
third is the function of Ag-specific B cells in the SED region and what 
relationship these have to the GC B cells. The fourth theme is the question of 
how re-utilization can occur of already existing GC in PPs and if this can be 
the basis for synchronization of the IgA LP response to high quality IgA 
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antibody responses. The fifth theme is the impact of germ free (GF) 
conditions on the gut IgA response and what role the CT adjuvant can have 
on the IgA response in GF mice. PP GC is a result of continuous exposure to 
the microbiota and food antigens. Hence, the PPs consistently host germinal 
centers (GCs) [110, 111]. The FDC network is a hall mark of the LZ while the 
network of CXCL12+ reticular cells (CRCs), which attract CXCR4hi cells, is 
seen in DZ region. Of note, the CRCs distribution is more extensive in PP GC 
than found in LN or spleen [110] [112].  
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2 AIM 
The general aim of this thesis work was to investigate B cell development in 
the gut; with focus on Peyer’s patches and Mesenteric lymph nodes as the 
inductive site and small intestine lamina propria as the effector site. 
2.1 Specific aims: 
 
• To study the kinetics of B cells expansion in the gut 
 
• Effects of migration of B cells within lymphoid tissues  
 
• Germinal centers expansion of B cell and the markers associated with 
it, importance of CD40-CD40L interactions  
 
• Antigen sampling by activated B cells from M cells in sub epithelial 
dome to maintain gut germinal center responses  
 
• Long lived memory B cells development by oral immunization  
 
• Ability of Cholera toxin in normalizing gut immune response in 
germ free animals  
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3 EXPERIMENTAL PROCEDURES 
This section provides an overview of the methods used in the study. A 
detailed description of all the experimental methods can be found in the 
attached papers. 
This study on IgA B cell biology has been thoroughly carried out using 
different mouse models. They were on C57BL/6 background and were 
housed in SPF or germ free conditions it our experimental biomedicine 
(EBM) facility at the University of Gothenburg, Sweden. To better control the 
bacterial microflora majority of the mice used in the experiment were bred at 
our facility. Mice were either used from experimental biomedicine facility, 
Gothenburg University or bought from Taconic farms (M&B, Lille Skensved; 
Denmark). The mice were all age and sex matched. The core of the thesis 
work has been based on adoptive transfer model developed in the research 
group. This transfer model we used NP-specific B-cell experiment mice 
generated through crossing C57BL/6 mice with homozygous B1-8high GFP 
mice [58]  [113] [114] (a gift from M Nussenzweig, Rockefeller University, 
New York, NY). For bone marrow chimeric studies and transfer studies, we 
generated GFPCD40-/- mice and NPGFPCD40-/- mice by crossing B1-8high GFP 
mice with CD40-/- for several generation and mice for experiment were 
generated. mT/mG (tdTomato) mice used in chimeric transfers were 
purchased from Jackson laboratory and are maintained at our animal facility. 
The germ free mice were acquired from our own EBM facility at the 
University of Gothenburg (Fredrik B).  
Immunizations 
Unless indicated immunizations with NP-CT (4-hydroxy-3-nitrophenylacetyl 
conjugated with cholera toxin [58] [115]) p.o was given at 10µg/mice and 
booster immunization of NP-KLH (500µg, Bio search technologies) was also 
administered along with NP-CT to get better NP specific responses. 
Response against NP has been well documented over the years and NP being 
a hapten cannot elicit an immune response all by itself but need a carrier 
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protein. Systemic response with NP-CT was obtained with a dose of 4 µg i.p 
immunizations. TI systemic response was achieved using 4 µg NP-Ficoll 
(Biosearch technologies) immunizations. For ligated loop assays NP-PE 
(5070-1 LGC Biosearch technologies) was administered to the loop at around 
200µg/loop.  For blocking internal migration, gut homing and GC disruption 
FTY720 (0.1mg/dose), CD40L (Bio X cell) and α4β7 (Bio X Cell West Lebanon, 
NH, 250µg/dose) blockade were used. More details on conjugation protocols 
and immunization dose and intervals can be found on the attached 
manuscripts. 
As the study is based on B cell activation and development we use the liberty 
of technologies like Microscopy, ELISPOT, Sequencing and FACs sorting to 
unravel the biology behind B cells activation.  
Work model 
A major part of the study has been carried out using adoptive transfer model 
system where NP-specific B1-8hi IgH knock-in λ-expressing GFP+ B cells 
transferred into normal recipient mice and then orally immunized the mice 
with NP-hapten conjugated to cholera toxin (NP-CT). This transfer system 
was redesigned in papers attached depending on the study, either changing 
the route of immunization or the antigen or by retransferring activated cells 
after this transfer procedure. Fig 2 shows typical response on D10.  (Detailed 
information’s on protocols used can be found in the attached papers). 
                 
 
Figure 2. Work model for the analysis of early and late expansion kinetics of NP-specific B cells 
following oral immunizations is represented in the left-hand side and the gating strategy of 
NP-specific B cells from CD19+ lymphocytes is shown in the right-hand side. 
 
B1-8hi/GFP
spleen cells
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WT mouse
Oral
immunization
Depletion non-B
and k+ B cells
PP and
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Bone marrow chimeras 
The role of CD40 proficient and CD40 deficient B cells in generation IgA 
plasma cells has not been studied; hence a bone marrow transfer system was 
designed after generation GFPCD40-/- mice by cross breeding, the 
experimental procedure shown at Fig 3 were performed. The advantage of 
such a system is, one essentially transfers a genotype of interest to the 
hematopoietic compartment of the recipient mice. Thus this system allowed 
us to compare the contribution of CD40 proficient and CD40 deficient B cells 
in developing IgA plasma cell responses under steady state. 
 
Figure 3. Bone marrow chimeric transfer model 
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Flow cytometry and cell sorting 
Flow cytometry along with immunohistochemistry was the central part of 
this thesis. FACs was used to study different marker expression on B cells 
and was mainly used to quantify the findings. In theory differently labelled 
antibodies were used to identify different extracellular and intracellular 
markers. Using unique laser settings in the FACs relative size and 
granularity can also be determined. In principle a single cell pass through a 
set of laser beams and the respective fluorochrome on the cell emits 
fluorescence. This fluorescence is detected by photo multiplying tubes 
(PMT). These signals are further converted to electronic signals which 
software converts to a numerical value on an analysis plot. By comparing 
specific fluorescent signals on each cell, one can study the expression level of 
different markers. B cell at different stages of activation was compared and 
quantified using this approach in the project. In FACs sorting cell with 
specific fluorescent profile can be sorted into tubes or plates. I could use this 
method to separate B cell expressing certain markers and further stain them 
or retransfer them into a host.  
 
Immunohistochemistry 
Immunohistochemistry is an excellent tool for qualitative information about 
the distribution of the cells and components in the tissue. This technique has 
been pivotal to this study as it enabled us to study cell activation, location at 
an early or later stage, cell migration, cell interactions etc. Major findings of 
this PhD thesis are based on this technique. In theory this technique has 
similarities with FACs as we use antibodies differentially labelled with 
fluorescent compounds are used to target specific markers on the surface or 
within the cell. The images of these fluorescently labelled cells in tissues has 
been acquired using the Zeiss LSM 700 inverted confocal microscope. 
 
RNAseq analysis 
RNA was isolated from the FACs sorted cells from spleen and PPs. This was 
sent to BGI for transcript quantification using the RNA sequencing after 
amplification using a SMARTer PCR cDNA Synthesis Kit (Takara Biomedical 
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Technology, Beijing, China). Comparing the expression was carried out by 
bioinformatics workflow (BGI Genomics, Hong Kong, China). Samples from 
PP (GL7+ or GL7- activated GFP+ and GL7+ germinal center or GL7- GFP- 
naïve B cells) were used. For expression analysis of specific transcripts, the 
PP populations were compared to GL7- GFP- naive splenic B cells; 
comparisons with individual splenic sample were made and had been 
prepared in parallel with the PP samples.  
 
Cannulation 
Thoracic duct cannulation provides an excellent tool to study the migration 
of lymphocytes. We used this approach to understand populations of B cells 
that migrate in the system. Protocols were carried out using standard 
established procedures [116]. Lymph was collected and FACs analysis was 
carried out to study these lymphocytes based on phenotypic markers they 
express. 
 
Ligated loop study 
One of the classical finding was conducted using loop study. Antigen 
sampling by activated B cell was visualized using this protocol. In short after 
transfer of cells on day 10 an incision was made along linea alba of the 
abdomen to expose the intestine. PPs were identified and ligated loops of 
intestine were made according to the protocol [117]. Antigen was injected 
inside the loop and mice were kept under anesthesia for different time 
duration to study Ag uptake mechanisms. 
 
In vivo Imaging 
Studies on activated B cell migration in the PP was conducted using in vivo 
imaging technique. A loop with one PP was surgically exposed and 
immobilized and analyzed under the microscope. This method helped us in 
understanding the internal migration of PP B cells within the micro anatomic 
structures of the PP. 
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Cloning and Sequencing 
Cloning and sequencing part was carried out to study memory B cells or 
LLPC from spleen, MLN, PP or BM. RNA was isolated followed by cDNA 
conversion and PCR using NP specific primers were used. This PCR product 
was later transformed and identified using colony hybridization protocol. 
Plasmid was isolated and either traditional Sanger sequencing was used 
where clones was analyzed using staden package. Clones were classified as 
NP binding if their CDR3 region was between 9 and 11 amino acids long, 
they had a tyrosine at position 99, and there were at least two more 
tyrosine residues in the following three amino acids. When NGS of NP-
binding gene sequences were undertaken, the Ion Torrent platform was 
used. Here nested PCR with FRW1 and IgA primers with barcodes was 
used to amplify purified DNA after eluting the DNA from NP specific 
PCR. After purification, of PCR product was loaded at 40 pM 
concentration onto Ion 314 v2 Chips using an Ion Chef and was sequenced. 
Sequences were aligned to V, D and J segments using IMGT/HighV-QUES 
[58]. 
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4 RESULTS AND DISCUSSION 
Paper I 
4.1 Biology of B cell expansion 
 
It is important to understand how immune responses in the gut are initiated 
following an oral immunization so that we may develop more effective oral 
vaccines [56] [118] [119].  Studies have suggested that the PPs are the critical 
sites for induction of gut IgA responses, but to what extent MLN, ILFs or 
even the  LP contribute to the response is poorly known [57, 58] [59] [61]. To 
answer these questions we developed an unique mouse model based on the 
adoptive transfer of NP-specific B1-8hi IgH knock-in λ-expressing GFP+ B cells 
into normal recipient mice and then orally immunized the mice with NP-
hapten conjugated to cholera toxin (NP-CT)  [58] [115] (M&M Fig 2). Using 
this adoptive transfer system it was found that after per-oral (p.o) 
immunization a dramatic expansion of NP-specific GFP+ cells were observed 
in the PP already on day 4 and the response peaked on day 10. Furthermore, 
we found a gradual engagement of proximal PPs on day 5 to involve also 
more distal PPs on day 10. Interestingly, whereas GL7 is commonly thought 
of as a marker for GC, the expression level of GL7 in PPs remained around 
20%, while this was higher than 80% in the spleen after an i.p immunization 
with NP-CT. Immuno-histochemical sections of PPs showed, however, that 
the GFP+ B cells were located to the GC in both the spleen and PPs. Of note, 
we observed a clearly less dense distribution of NP-specific GFP+ cells in PP 
GCs compared to that observed in MLN or in SP (Fig 4). 
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Figure 4. PP, MLN and SP D10 sections after immunization. Green-GFP+NP specific B cells, 
Blue-B220+Bcells, Red-GL7+ germinal center cells 
4.2 Migration of activated B cells 
We have shown in a previous study [115] that activated B cells from one PP 
can migrate into multiple PPs where they appear to undergo differentiation. 
Here we studied the role of B cell migration following oral immunization in 
greater detail. We used FTY720 to block egress of activated B cells from the 
inductive sites in the PPs [120] [121] [122] [123]. We administered FTY720 to 
achieve complete or partial blockade following oral immunization with NP-
CT. We observed after FTY720 treatment from day 0  a dramatic drop in NP-
specific GFP+ cells in the PPs, but when FTY720 was given from day 3 we 
observed an increase in NP-specific GFP+ cells in PP and , in particular, in the 
MLN, strongly arguing for an early migration from inductive sites in PP to 
other PPs and the MLN.  We observed a 3-fold increase in NP-specific GFP+ 
cells in MLN. Immuno-histochemical sections showed a reduction in NP-
specific GFP+ cells in the GC in PPs after FTY720 treatment from day 0. It is 
interesting to notice FTY720 treated group showed a decrease number of 
GFP+ plasma cells in villi close to PP and the opposite finding in the 
untreated group. Our findings suggested that FTY720 treatment prevented 
early migration of B cells from PP-inductive sites to multiple PPs at more 
distal sites. It appears that the PP B cell affects the NP specific B cells in MLN, 
because the delay in FTY720 treatment to day 3 strongly augmented the 
presence of NP-specific B cells in MLN [60] [121] [122]. 
 
PP Day 10
200µmB220/GFP/GL7
PP Day 10 Spl Day 10 (i.p. imm)
B220/GFP/GL7 100µm
Spl Day 12 (i.p. i )
20µm10
MLN Day 10
B220/GFP/GL7
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The studies suggested an early migration of activated NP-specific GFP+ cells 
from PPs to MLN and then into the blood to finally arrive at distal PPs. The 
activated PP B cells could have left via the draining lymph at an early time 
point after immunizations. To investigate this possibility we undertook 
experiments with surgical cannulation of the ductus thoracicus. Two groups 
of animals were used, one with intact MLN and another with the MLN 
removed (MLNX). 
 
In both groups we identified activated B cells; i.e CD19+ IgD- GL7+ cells 
around (0.1-0.15 %) as well as CD19+ IgD- GL7+ CD73+ cells, which suggested 
a GC origin. These findings suggested that irrespective of the MLN, GFP+ 
cells could pass into the draining lymph and migrate into the blood to home 
back to multiple PPs in the distal gut. In order to test this notion we 
performed surgical cannulation of the thoracic duct after the transfer of NP-
specific GFP+ cells and oral immunizations. An early (D5) and a late time 
point (D8) was studied, GFP+ B cells and GFP+ plasma cells were both 
identified at these time points, further strengthening the idea  of migration of 
NP-specific GFP+ cells at an early time point to other PPs and the  MLN via 
the draining lymph. This way we could explain how synchronization of gut 
IgA plasma cell responses can occur [115] [56].  
4.3 Requirements for the re-utilization of germinal centers 
To study the conditions required for the re-utilization of already existing GC 
in multiple PPs we postulated that presence of antigen could be a critical 
component. We speculated that antigen had to be delivered 1 day before the 
transfer of activated GFP+ PP B cells to allow the cells to accumulate in the 
PPs of recipient mice. We administered NP-CT orally 1 day before or 1 day 
after the adoptive transfer of activated PP B cells. While naïve GFP+ B cells 
expanded in PPs even when antigen was given 1 day after transfer the 
activated PP B cells only accumulated in PPs when antigen was given 1 day 
before transfer. Thus, antigen is critical for the re-utilization of pre-existing 
GC in PPs of the recipient mice. When recipient mice were given anti-CD40L 
Mab to eliminate existing GCs the accumulation of B cells in PPs was 
interrupted. There was a dramatic loss of GFP+ B cells in PPs and a severe 
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reduction of plasma cells in the LP (Fig 5). This explains how we can achieve 
a synchronized gut IgA plasma cell response. 
 
 
 
Figure 5. The graph shows adoptively transferred activated GFP+ B cells from PP were, 
indeed, capable of repopulating recipient PPs in the presence of antigen while in CD40L 
treated recipient group, GFP+ B cells were not able to differentiate. Right panel shows 
adoptively transferred activated GFP+ B cells from PP are capable of entering the germinal of 
the recipient mice while CD40L treatment destroyed the germinal center structure, Non-
immunized group is kept as the control 
 
We further studied the role of CD40-expression on activated NP-specific 
GFP+ cells for the ability to re-utilize existing GC in multiple PPs. NP-specific 
GFP+ cells from different sources were compared. Splenic cells from CD40-
deficient mice or wild type (WT) mice were compared following NP-Ficoll 
(T-cell independent) immunizations or after oral NP-CT (T-cell dependent) 
immunizations. As a positive control we used oral priming with NP-CT. All 
recipient mice received an oral dose of NP-CT 24h before the B cell transfer. 
We observed that both splenic and PP cells activated by NP-Ficoll (TD) or  
NP-CT accumulated in the PPs irrespective of if they represented TD or TI-
type of responses. By contrast, CD40 deficient B cells from NP-Ficoll 
immunized mice did not accumulate in the PPs of the recipient mice. Hence, 
it can be concluded that B cells activated by TI antigens appear also to 
accumulate in PP and could possibly also benefit from exploiting the GC. Of 
note, no cognate interaction was required in this process, but the presence of 
Ag and CD40L –CD40 interactions were critically needed. It, thus, appears 
that both type of B cell responses, TD and TI-type, can re-utilize already 
existing GC in the PPs. Interestingly, cognate interactions with antigen-
specific TFH cells seemed not to be required by already activated B cells when 
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re-utilizing an already existing GC in multiple PPs.  Whereas the TFH 
population is critical for the GC reaction, its prime function in PP GCs 
appears to be CD40L expression to support B cell affinity maturation and IgA 
CSR.   
4.4 Bone marrow chimeric transplant confirming the role 
of CD40-expression in gut IgA plasma cell generation 
 To study the role of TD and TI type of  B cell responses in the gut we 
generated chimeric mice by transplanting bone marrow from GFP+ CD40-/- or 
mT/mG (tdTomato) WT mice into irradiated WT mice. The aim was to test 
whether CD40-proficient or CD40 deficient B cells contributed to the IgA 
response in the gut LP. Strikingly, we observed a dramatic loss of the GFP+ 
gut IgA plasma cells, while the proportion of mT/mG BM derived WT IgA 
plasma cells was unperturbed, indicating that B cells need CD40-expression 
to be competitive in the GALT (Fig 6). The complete loss of GFP+ B cells was 
obvious in the gut LP, whereas it was not seen in peripheral blood, MLN or 
the PPs (15-20% GFP+ and 20-25% mT/mG B cells). This distribution of B cells 
was also reflected in the distribution of CD4 T cells of the GFP+ or mT/mG+ 
origin in the different tissues. In contrast, the gut IgA plasma cells were 
exclusively derived from CD40-proficient B cells with minimal numbers of 
CD40-/- GFP cells, arguing that CD40 expression is critical for the B cells to 
enter GC in the PP to undergo proliferation and affinity maturation prior to 
homing to the gut LP as IgA plasma cells. In conclusion, this experiment 
proved that CD40-expressing B cells, even activated with TI antigens, can re-
utilize already existing GC in multiple PPs. CD40-expression is required for B 
cells  to undergo expansion and differentiation in PP GC. 
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Figure 6. Representation of LP after the transfer of GFP and mT/mG cells. IgA positive cells 
were exclusively from the CD40 proficient origin. IgA-white, mT/mG CD40 proficient- Red, 
GFP CD40 deficient- Green. 
 
Earlier studies suggest gut IgA antibodies must be of sufficient quality to 
effectively protect against pathogen [124]; this is achieved by re-utilization of 
germinal centers resulting in a clonal expansion of B cells [115]. In this study 
we demonstrates that re-utilization of pre-existing unrelated GC, in multiple 
PP can occur and is achieved through an early migration from the inductive 
site in proximal PPs, via the draining lymph and blood. For the accumulation 
of activated B cells in the PP GCs two important factors are required, 
presence of antigen and CD40-expression on the migrating B cells, 
suggesting that perhaps cognate interactions in the PP GC are not required 
for further propagation and differentiation of activated PP B cells. Bone 
marrow chimeric studies were undertaken and indicated that B cells, even 
when activated by luminal TI antigens, can enter PP GC to further 
differentiate. 
 
mT/mG
GFP
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Paper II 
4.5 Germinal center dynamics 
 
Germinal centers in PPs are different from GCs in other lymphoid tissues in 
several ways [125] [126] [127]. One important difference is that they are 
constantly present in PPs due to the gut microbiota. This makes it difficult to 
study the induction of a specific GC response in the PPs following oral 
immunization. Whereas antigen is travelling with the lymph or on migrating 
DC through the afferent lymph to peripheral lymph nodes, the way antigen 
gets access to the PP is through the FAE and more specifically the M cell up-
take of antigen from the lumen [128] [129]. However, we still lack precise 
information about how antigen is transported from the M cell to the B cell 
follicle. It has been demonstrated that DCs play a critical role for this 
transport, but also B cells have been implicated in this regard. Yet, another 
question to answer is whether there is any selection of antigen from the 
myriad of antigens present in the gut lumen to promote a specific response. 
In this regard the B cells with their specific receptors would serve such a 
function if they were involved in antigen transport in the PP. Using our B1-
8high adoptive transfer model we investigated the role of the B cells in the SED 
for an antigen transport function. Following oral immunizations with NP-CT, 
a majority of NP-specific GFP+ B cells were found to be in the GC. A FACS 
analysis of these cells demonstrated that most of the GFP+ cells were 
activated IgD- (> 90%), An unexpected finding was that only 20% of these B 
cells expressed GL7, which is traditionally viewed as a marker for GC B cells. 
This contrasted with the fact that more than 80% of the activated IgD-GFP+ B 
cells in the spleen were GL7+. Moreover, in the spleen GC the GFP+ B cells 
were dense, whereas in PP GC they appeared much less densely packed with 
GFP+ B cells. These findings indicate that the PP GCs regulatory 
microenvironment may be different from that found in other secondary 
lymphoid organs and spleen. A detailed analysis on the tissue sections of PP 
GCs showed proliferating (Ki67+) GFP+ B cells that were dominated by GL7- 
cells (Fig 7). Their GC nature was confirmed by BCL-6-expression in both 
GL7+ and GL7- GFP+ B cells. The GL7-reactive antibody used to define GC B 
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cells detects α2,6-linked N-acetylneuraminic acid on glycan chains, an 
epitope highly expressed in GC B cells due to lost expression of CMP-
Neu5Ac hydroxylase (CMAH) [130]. Therefore, in mice that lack CMAH all B 
cells express high levels of the GL7, which results in a state of hyper-
responsiveness to Ig-crosslinking.  
 
  
Figure 7. Close-up confocal microscopy image on a GC in PP with GL7+ (white) or GL7- 
proliferating Ki67+ (blue) GFP+ (green) B cells B220+(red) and examples of labelling patterns 
of activated NP-specific GFP+ or non-specific GFP- B cells in the GC image. 
 
The GC can be divided into a light and a dark zone [131] [132] [133]. To 
understand the role of the GL7- GFP+ B cells we analyzed their distribution in 
these GC zones, to see if they could be associated with a functional stage of 
GC B cell differentiation. However, we observed no clear pattern as the GL7- 
GFP+ B cells appeared to be equally present in the light and dark zones. 
Furthermore, we performed an extended phenotypic analysis by FACS of the 
GL7- and GL7+ GFP+ B cells. We found that the GFP+ IgD- cells were CD38- PP 
B cells and shared all of the activation markers that we tested for. Hence, it 
appeared that the two GC B cell populations were similar and identical to the 
endogenous GC population (GL7+B220+GFP-), but phenotypically different 
from naive B cells (GL7-IgD+GFP- B cells). To investigate whether the GL7- 
phenotype was stable we isolated GFP+ GL7+ and GFP+ GL7- cells by FACS 
GFP Ki67 GL7
GFP+Ki67+GL7-
GFP-Ki67+GL7+
GFP-Ki67+GL7-
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sorting and transferred them into hosts that were given NP-CT 24hr prior to 
the transfer. We found that both populations accumulated in the PP GC and 
both populations gave rise to a distribution of 20% GL7+ and 80% GL7- GFP+ 
IgD- B cells in the recipient PP. This suggested that the GL7 phenotype in PP 
GC is not stable, but rather appears reversible as B cells can upregulate and 
downregulate GL7 during the different stages of differentiation.  
4.6 Gene expression profiles of GL7+ and GL7- 
 
The studies on GFP+ B cells in PP GC showed that the GL7-marker could be 
expressed at different stages of GC development. To better understand if the 
GL7-expression could identify a distinct stage of differentiation we 
undertook an RNASeq analysis of the sorted PP B cells. We found that the 
gene expression pattern in both GFP+ B cell subsets were largely similar to 
the one obtained from the endogenous GL7- GFP- PP B cell population. The 
global gene expression heat maps showed GL7+ and GL7- B cells from 
activated NP-specific GFP+ cells to be similar to endogenous GL7+ B cells. 
This was further confirmed in the principle component analysis (PCA) of the 
global gene expression profile that was found with activated GL7+ GFP+ cells, 
showing that, indeed, GL7- and GL7+ GFP+ B cells were very similar, albeit 
not identical .For example, the EBI2 gene has been linked to B cells migrating 
to outer follicular regions (OFR) [134], and, hence, repression of this gene 
supports a GC localization and relates to the upregulation of BCL6 [130, 134]. 
In our RNASeq analysis EBI2 was seen differentially expressed in GC GL7- 
and the GL7+ B cell subsets. Hence higher EBI2 gene expression on GL7- 
population could be a requirement for GL7- GFP population to leave the GC 
and migrate to the subepithelial dome (SED) region. 
 
Gene expression levels of CD83, CD86 and CXCR4 were similar in both GL7+ 
and GL7-  GFP+ B cells, supporting the notion that there should be no major 
differences in light/dark zone distribution between GL7+ and GL7- B cells. 
Similar expression levels of CXCR4 in both the populations, perhaps, 
associated with a similar tendency to leave the PP [108]. More importantly, 
the PP GL7- GFP+ B cell  population showed a gene expression prolife often 
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associated with memory B cell development with higher expression of EBI2 
(Gpr 138), CD38, CCR6, which  indicated differentiation towards a precursor 
memory or memory B cells stage [135] [136] [137]. The two populations also 
differed with regard to CCR6 gene expression, which was recently shown to 
be linked to a pre-memory stage of B cell differentiation [138] [139] [134]. 
Alternatively, the higher expression of CCR6 and CCR1 mRNA could 
indicate trafficking of GL7- GFP+ B cells to the SED [99]. 
4.7 Distribution of GL7- phenotype 
We have previously reported that IgA CSR is effective in the GALT of CD40-
/- mice. The B cells undergoing IgA CSR in CD40-/- mice were found to be 
GL7intermediate and it was thought to be at a stage of differentiation prior to a 
manifest GC stage. This IgA CSR could have occurred in the SED as B cells 
express AID in SED [140] [139]. In the PP there are two major compartments 
where the activated NP-specific GFP+ cells are found following oral 
immunization, namely in the GC and the SED region. Therefore we 
examined GC and SED regions in detailed for GL7+ and GL7- GFP+ B cells. We 
observed dividing Ki67+, GFP+ B cells in both the GC and SED regions (Fig 8). 
On further examination we observed that the GFP+ B cells in the SED region 
were GL7- and expressing CCR6. Of note, B cells undergoing IgA CSR in SED 
were reported to be mainly IgD+ CCR6+ and, thus, different from the 
GFP+IgD-CCR6+ B cells we observed [99], the proportion of GFP+ cells that 
expressed AID in SED was significant, which argues against a memory 
phenotype. It appeared that some GFP+ cells had switched to IgA, but IgA-
expression was low, speaking against differentiation of plasma blasts in the 
SED. The most striking and unexpected finding in the SED region was the 
presence of GFP+ B cells in close proximity to GP-2 expressing M cells. It was 
clear that the B cells were not just randomly distributed close to the 
epithelium as few cells were close to EpCAM+ epithelial cells. We interpreted 
this location to be important and reflecting a function of GL7- GFP+ cells in 
the SED and we hypothesized that these B cells acquired luminal antigens 
taken up by the M cells. 
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Figure 8. Representative microscopy images showing activated proliferating Ki67+ (red) 
GFP+ B cells (green) in the SED and GC on day 10 following oral immunization with NP-CT 
4.8 Antigen uptake by GFP+GL7-CCR6+ B cells 
Activated GFP+GL7-CCR6+ B cells were seen in close proximity to the M cells 
of the FAE in PP. The presence of activated antigen specific B cells in both 
SED and GC suggested that the B cells could move from one region to 
another within the PP. To address this question we initiated collaboration 
with Ziv Shulman at the Weissman Institute in Israel. Together we could 
demonstrate that photoactivatable (PA-GFP) B1-8hi B cells migrated from the 
SED to the GC in the PP at day 8 followed by oral immunization with NP-CT 
[141] [142]. Photo-activation sites were marked by co-transferring B1-8hi B 
cells expressing cyan fluorescent protein (CFP) to AID-Cre tdTomato mice to 
visualize SED and GC regions. Tracking of the photoactivated B cells showed 
that 40% of SED B cells appeared in the GC area, while movement of GC cells 
to the SED was less clear. Hence it was concluded that during an ongoing 
response in PPs the B cells move from SED to GC, and, perhaps, also from 
the GC to the SED region. Further studies are required to analyze whether 
IgA CSR occurs in the SED region. 
 
Because the GFP+ B cells were in close contact with the M cells in the SED 
region and could move towards the GC, we speculated that they could 
GFP
Ki67/Ki67
PP
GFP
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perform an antigen transporting function in the PP. For trafficking of B cells 
from SED to GC or GC to SED the expression of migratory markers like 
CCR6 and CXCR5 will be critical.  To test whether the B cells could acquire 
antigen from the M cells we injected NP-PE into ligated loops of the small 
intestine 10 days after the transfer of cells and oral immunization with NP-
CT. We found that at 1hr following injection of antigen a significant number 
of GFP+ B cells carried NP-PE. The percentage increased even more and  after 
2hr following injections into the ligated loops  nearly 50% of CCR6+ GL7- SED 
NP-specific GFP+ cells were PE+, while around 20% of CCR6-GFP+ B cells had 
bound PE labeled antigen. By contrast, the  endogenous B cells (GFP-), or  
GFP+ B cells from PPs outside the loop, or inside a loop injected with PE 
alone all had few PE-labeled cells, indicating that only NP-specific B cells 
could capture the  luminal NP-PE antigen. Also the frequency of PE+GFP+ B 
cells was highest in SED compared to GC (CCR6-GL7+), supporting the 
notion of an antigen-transporting pathway from SED to GC. An immuno-
histochemical analysis confirmed that M cells had, indeed taken up NP-PE 
from the lumen of the loops (Fig 9). NP-PE was bound to the GFP+ B cells at 
the basal pockets of the M cells (Fig 9). Taken together it appeared that 
antigen-specific B cells in SED interact closely with the M cells to bind 
antigen taken up from the gut lumen. The SED B cells migrate with antigen 
to the GC, which could be a mechanism for perpetuating the GC reaction for 
as long as the B cells can bind luminal antigen in the SED. It can be 
speculated that if this antigen uptake pathway is disrupted or M cell function 
is lost it can severely affect IgA antibody responses in the gut [143] [129].  
 
Figure 9. Representative confocal microscopy image of antigen accumulation (NP-PE; red) to 
M cells (GP2+; white) in the FAE of a PP at 30 min. following inoculation of a loop with NP-
PE. Also depicting dendritic cells (CD11c; blue) in SED (panel 1). NP-PE antigen (red) 
located to M cells (GP2+; white) and not to the EPCAM+ epithelium. GFP+ B cells (green) in 
close proximity to or even surrounded by M cells (panel 2 and 3) and GFP+ B cell in SED 
carrying NP-PE and DC (CD11c+; blue) (panel 4). 
NP-PE/CD11C/GP2
100µM
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Paper III 
4.9 Poor clonal relatedness of long lived plasma cells and 
memory B cells 
A critical question to answer is whether oral immunization can stimulate a 
long lasting memory [144] [145] [146]. This is essential if oral immunizations 
are to be considered for long term protection against invading pathogens. 
Evidence from several clinical vaccine trials have indicated that memory may 
be short lived following oral vaccination. Therefore we studied the 
development of long lived plasma cells and memory B cells after oral 
immunization. Following three oral immunizations with NP-CT at 10 days 
apart, clonal relatedness of long lived plasma cells and memory B cells were 
investigated. In the first part of the study we used the traditional Sanger 
sequencing technique to sequence the VH186.2 heavy chain V region gene, 
encoding NP specificity. We found that long lived IgA and IgG plasma cells 
in the bone marrow (BM) were clonally closely related and exhibited a 
similar frequency of mutations. Nearly 50% of the sequenced IgA genes 
carried the high-affinity mutation, characteristic for the NP-response. 
Moreover, IgA and IgG NP-binding B cells in the small intestine (SI) LP and 
BM were also clonally related. 
 
We established clonal trees to picture clonal relatedness in the NP-specific 
memory B cells and long lived plasma cells. We found that the memory B 
cells and long lived plasma cells that resulted after oral priming were 
clonally poorly related as determined by a global gene analysis using NGS of 
sorted IgA+ cells from different tissues. This was a surprising finding and 
suggested that memory B cells had, in fact, left the GC at an earlier time point 
than the plasma cells or was derived from a uniquely different inductive site. 
But upon reactivation of memory B cells it was observed that NP-specific 
memory B cells in PP and plasma cells in the LP exhibited strong clonal 
relationships, arguing that reactivation of memory B cells initiated a second 
round of strong selection and maturation into plasma cells. These expanding 
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memory B cells in PP and the IgA plasma cells in the gut LP were closely 
related. It appears rational that memory B cells following oral priming 
should have a  broader, less mutated, repertoire of IgM+ and IgA+ cells and 
that upon re-exposure to antigen the memory B cells undergo somatic 
mutations to acquire a less broad more effective protective population of 
high quality IgA antibody producing plasma cells in the gut 
4.10 Memory B cells from oral immunization 
NP-specific memory B cells were extremely rare at 1 year after oral 
immunizations, numbering somewhere in the ratio 1:100,000 B cells. Yet a 
booster dose at 1 year after the mice were orally primed resulted in a rapid 
increase in antigen-specific IgA antibody forming cells (AFCs) in the SI LP. 
From 1:100,000, the NP-specific B cells made up to 15% of all IgA plasma cells 
in the SI LP after 1 week following the oral booster immunizations. This 
increase was also seen in IgA and IgG AFCs in the spleen and BM, as well as 
an increase in serum NP-specific antibodies. Most interestingly, though, was 
the observation that  NP-specific IgA memory B cells carried more mutations 
than was found in the long-lived plasma cells, suggesting that they were 
clonally unrelated. However, NP-binding IgA sequences shared clonal origin 
irrespective of if they were isolated from (SP, BM or SI LP) arguing for a 
highly effective clonal selection process following a booster immunization. 
Thus, it can be concluded that oral priming immunizations effectively 
promoted the development of antigen specific memory B cells at mucosal 
and systemic sites.  
 
Next we analyzed if systemic immunizations could stimulate a gut mucosal 
IgA response or not. The route of immunization has been suggested to be 
critical for a strong gut IgA response. To this end we undertook to i.p prime 
mice, which was then followed by an oral boost with NP-CT to stimulate 
both an anti-NP and anti-CT IgA response in the SI LP and in serum. 
However, we failed to observe any gut IgA AFC response after a p.o boost to 
i.p primed mice.  By contrast, an i.p. boost to p.o. primed mice was effective 
at eliciting a gut IgA AFS response, comparable to those seen after a p.o boost 
to p-o primed mice. Noteworthy, oral and systemic priming with NP-CT 
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were similarly effective at promoting serum anti-NP and anti-CT IgG 
responses. Hence it can be concluded that p.o immunizations are much more 
effective than systemic immunizations at generating memory B cells, that 
provide both a gut mucosal IgA and a systemic IgG antibody response. Only 
oral priming imprinted gut homing properties in memory B cells, while 
systemic priming did not affect the expression of CCR9, required for homing 
to the SI LP 
 
A unique feature of the PP is the continuous presence on GCs because of the 
gut intestinal microbiota. IgA memory B cells dominated in the PP after oral 
immunizations, but at all other sites these cells were predominantly IgM. 
Hence, in SP and MLN a majority expressed IgM, while 20-40% expressed 
IgG and very few were IgA memory B cells. Memory GFP+ B cells in these 
organs had a resting phenotype (GL7-CD38+) and were distinctly different 
from activated B cells (GL7+CD38-). Interestingly, the memory GFP+ B cells 
(B2220+, GL7-CD138-) were located to the B cell follicles close to GC in all the 
organs that we analyzed. We think this may be critical for the effective 
selection process in the secondary GC when reactivated by a booster 
immunization. Upon re-activation of memory B cells (with a very low 
frequency among all B cells in the lymph node or PP ; <0.02%) memory B 
cells exhibited an exceptional expansion and differentiation upon 
reactivation. The presence of memory B cells expressing IgA in PP contrasts 
with previous reports, showing that mostly IgM+ memory B cells should be 
expected in lymph nodes following immunization [147]. 
 
Also oral priming of NP-specific GFP+ cells resulted in expression of 
significant levels of the gut homing receptor α4β7 in PP and spleen, while i.p 
priming did not result in α4β7 expression. When an anti- α4β7 monoclonal 
antibody (Mabs) was used to block gut homing, we found significantly fewer 
NP-specific GFP+ plasma cells in the SI LP after p.o or i.p booster 
immunizations. This observation confirmed the requirement for α4β7 
expression for gut homing of plasma cells to the SI LP. . Both splenic and PP 
memory B cells expressed the α4β7 homing receptor following oral 
immunization, but CCR9 was acquired only in the PP upon a booster 
immunization and not in the spleen. Collectively, these observations 
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suggested that memory B cells following oral immunizations acquire gut 
homing receptors and are recirculating cells residing in both systemic 
lymphoid tissues and the GALT. Upon reactivation they effectively can 
home back to the gut LP provided the memory B cells enter the PP or, 
perhaps the MLN, where they acquire CCR9 expression which enables them 
to home to the gut LP. So mucosal memory B cells require both α4β7 and 
CCR9 to successfully home to SI LP 
 
Another important observation was that NP-specific GFP+ memory B220+ 
cells expanded close or within GC in the PP when responding to recall 
antigen. Resting NP-specific GFP+ memory cells (CD19+B220+CD138− B cells) 
co-express CD73 and CD80 while the PD-L2 marker was downregulated 
on a majority of responding memory B cells after reactivation. Therefore, 
we believe CD73 is an excellent marker that identifies resting and 
activated mucosal memory B cells. We observed that B cells with a 
memory CD73+ phenotype increases with age in PP, which is supported 
by the finding of  Linder et al., that B cells in GALT progressively 
accumulate somatic mutations in IgA V region genes [148] [149]. Hence, 
the PP GC is important for the development of memory B cells following 
oral immunization and when the GC is disrupted by administration of 
anti-CD40L Mab during an ongoing immune response, a significant 
reduction of memory B cells was observed. 
 
Paper IV 
4.11 Inductive sites (PP) of Germ free mice appears normal 
while the effector site (LP) exhibit poor IgA plasma cell 
response 
It is well known that the microbiota is important for the gut 
microenvironment and critical for allowing guts IgA responses to TD and TI 
antigens [150] [151] [152]. Previously, we showed that CD40-/- mice had near 
normal levels of IgA+ plasma cells in the gut, despite no GCs and that they 
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did not respond to oral immunizations with TD antigens [140]. The 
hypothesis is that the microbiota is critical for the performance of the IgA 
inductive site in the PPs [153] . But, it has been incompletely investigated and 
it could equally well be that the effector site (SI LP) in the absence of the 
microbiota does not support and maintain a plasma cells response. For this 
study we used germ free (GF) mice to better understand the impact of the 
commensal flora on IgA plasma cell responses. We investigated both the 
inductive (PP) and the effector sites (LP). We could confirm previous 
observations of a near complete lack of IgA plasma cells in the LP [154]. 
Unexpectedly, however, we found the PP compartment exhibited normal 
frequencies and sizes of GC as well as an unperturbed FDC network (CD35), 
normal AID expression and IgA B cell frequencies mimicking what can be 
observed in conventionally reared mice.  This drop in LP IgA plasma cells 
was detectable as 90% reduction in IgA AFC in GF compared to normal mice. 
Serum IgA levels were also reduced whereas serum IgG and IgM were not 
significantly altered. Using the adoptive transfer model with B1-8hi NP-
specific IgH knock-in GFP+ B cells we found intact GC formations and strong 
GFP+ B cell responses in the PPs following oral NP-CT immunizations [58]. 
Thus it appeared that the PP inductive sites were unperturbed and 
functionally normal despite the lack of microbiota. 
4.12 IgA CSR environment appears normal in GF mice 
Next we investigated if we could observe IgA CSR in the PPs and so we 
analyzed if the GF mice expressed normal levels of genes encoding factors 
that are required for IgA CSR. To this end we analyzed by qPCR a set of 
genes known to influence IgA production. However, we found in GF mice 
that PPs expressed normal levels of most of the genes, including genes 
encoding BAFF, APRIL, IL-5, IL-6 and IL-10. The exception was mRNA 
expression of the Nod2 encoding gene, which showed an upregulated 
expression and the gene encoding iNOS gene which was down modulated 
compared to that found in conventional mice. This is in line with previous 
observations showing that iNOS-/- mice have lower levels of IgA producing 
cells in the gut LP [155]. Thus, our analysis of the PP-inductive site in GF and 
conventional mice revealed no major alterations in the expression levels of 
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genes directly or indirectly involved in IgA CSR or IgA B cell responses. 
Moreover, the level of AID mRNA expression in PPs did not differ from that 
in conventional mice. Most importantly direct evidence for IgA CSR was 
obtained from PP from GF mice as we could detect unaltered levels of 
germline α-transcripts and post-switch α-circle transcripts,. These findings 
indicated that in GF mice the inductive site for IgA responses appears 
normal. Thus, food antigens or endogenous non-bacterial antigens could 
clearly activate IgA B cell responses in the PP of GF mice.  
4.13 The gene expression profile of the LP effector site is 
altered in GF mice  
Because we did not find a crippled IgA B cell inductive site in the PPs of GF 
mice we extended our analysis to include whether B cells left the inductive 
site to travel to the effector site. We used a technique by which we 
cannulated the thoracic duct lymph in GF and conventional mice and 
followed the drainage of B cells and plasma blasts coming from these. We 
observed no major change in the composition or numbers of activated B cells 
or plasma blasts that left the PP inductive site for the LP effector site in GF 
mice. Hence, similar frequencies of PP B cells were observed in GF and 
conventionally reared mice. 
 
Whereas the PP-inductive site and the egress of activated B cells and plasma 
blasts in the draining lymph were unperturbed in GF mice we focused our 
attention to the effector site in the LP of the SI. Therefore, the next step was to 
investigate whether we had normal conditions at the effector site to host the 
gut homing B cells and plasma blasts. To identify possible signalling 
pathways involved in such a process we screened SI LP biopsies for a set of 
genes known to be involved in plasma cell differentiation and survival using 
a qRT-PCR. We found that the PCR- array revealed that genes encoding 
iNOS, IL-5, IL-6, and IL-10 were clearly reduced as well as genes encoding 
bacterial recognition, such as the Nod1, Nod2, TLR4 and TLR9 encoding 
genes. Notably mRNA expression of BAFF and APRIL mRNA genes were 
not significantly different to conventionally reared mice.  These finding lead 
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us to conclude that the microenvironment in the gut LP effector site appeared 
dramatically altered from that observed in conventionally reared mice.  
4.14 The effector site can be restored by oral administration 
of CT  
Oral administration of CT adjuvant could potentially restore the defect 
microenvironment seen in the LP effector site in GF mice. Following oral CT 
we observed a strong increase in total IgA AFC in the LP. This increase was 
only partially explained by the presence of CT-specific IgA AFC, and 
suggested a pharmacological effect of CT on the microenvironment of the LP 
effector site in GF mice.  Immune histochemical analysis of gut tissue sections 
from CT-treated GF mice or re- colonised GF mice showed comparable levels 
of IgA plasma cells in the LP. Also, the levels of CD4 T cells were restored 
compared to that observed in conventionally reared mice.  
 
Thus, the change in CD4 T cells might play a role in restoring IgA plasma cell 
levels in the LP of GF mice. Also there was an expansion of CD11c 
population in CT-treated GF mice as also seen in re-colonized GF mice.  
Retinoic acid (RA) has been shown to have an important role in imprinting 
gut tropism of IgA committed B-cells [77, 78, 156]. In the GALT DCs produce 
RA, which is an important element for the expression of gut homing 
receptors α4β7 and CCR9 on activated B and T-cells? It is possible that a lack 
of RA in the DC population in GF mice can be restored or compensated for 
by treatment with CT adjuvant. However, we did not find a reduction in 
CCR9-expression in PP B cells, hence this notion is unlikely. Rather, the DC 
at the effector site could be lacking RA, but whether this can account for 90% 
reduction of gut IgA plasma cells in GF mice waits to be further investigated.  
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5 CONCLUSION  
Paper 1: Following oral immunization NP-specific GFP+ B cells enter the 
proximal region of PP and starts to proliferate and later clonally related PP B 
cells are evenly distributed in the Gut associated lymphoid tissues (GALT). 
This occurs in the presence of antigen and by  CD40-dependent fashion. 
Migration of activated cells occurs via blood and lymph. Later stages they are 
seen in the small intestine lamina propria (SI LP) as plasma cells. 
 
Paper 2: In an ongoing immune response to an oral antigen activated NP-
specific GFP+ B cells can take part in antigen sampling. They are seen either 
in close proximity or interacting with the basal pockets of M cells carrying 
antigen. These cells can move towards germinal center to present antigen 
and presumably for an effective germinal center (GC) response. 
 
 
 
 
 
 
 
 
Figure 10. Antigen sampling by activated B cells from FAE region. GC- germinal center, 
SED-sub epithelial dome, LZ-light zone, DZ-dark light, DC-dendritic cell, M cells-microfold 
cells, Ag-antigen. 
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Paper 3: Following immunization we hypothesis the plasticity of GALT 
allows the generation of memory B cells and long-lived plasma cells 
(LLPC), but involving temporarily separate processes in the GC or even 
anatomically separate GC, leading to lower-affinity maturation in 
memory B cells. This allows for a broader, less mutated, repertoire of both 
IgM+ and IgA+ mucosal memory B cells following oral immunization than 
that ultimately used for host protection. On re-exposure to antigen, gut 
memory B cell clones have migrated to multiple sites in the GALT and the 
response can be synchronized and clones strongly selected, leading to 
clonal relatedness in the GALT and SI LP with only high-affinity and 
strongly mutated clones being represented. 
 
 
Figure 11. Activated B cell undergoing two separate pathways for becoming high affinity 
matured LLPC and low affinity matured memory B cells, on reactivation, these memory B 
cells can undergo further maturation and arises to clonally relate synchronized response in 
GALT. 
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Paper IV. The effector site lamina propria (LP) of GF mice has low levels of 
secretory IgA (SIgA), while colonization or oral immunization with CT 
restores IgA plasma cell responses. Hence we propose GF mice host a 
defective effector site and that oral CT or bacterial colonization provide 
compensation for lack of environmental cues necessary for plasma cell 
maintenance or survival in LP 
 
Figure 12. Oral immunization of GF mice with CT or bacterial colonization restore plasma 
cell in the gut LP, IgA- green, IgM-red, EpCAM-blue 
 
100µm100µm
 Small intestine
 Colonised EpCAM IgA IgM Germ Free
Small intestine
EpCAM IgA IgM
 Small intestine
 CT treated EpCAM IgA IgM
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